Metabolomics analysis of breast cancer patients data sampled randomly to generate distributions similar to those reported e.g. in (Terunuma et al., 2014). The data is stratified by estrogen receptor (ER) expression status (group1 = ER+, group2 = ER-). Each group is given as a sub-list containing 'data' (raw data, metabolites in columns and samples in rows) and 'identifiers' (one column per identifier, rows in the same order as the metabolites order in 'data').
metabolite_dataER+ data
ER- data